Search

Your search keyword '"Gratacós, Jordi"' showing total 11 results
Start Over Author "Gratacós, Jordi" Publisher elsevier espana
11 results on '"Gratacós, Jordi"'

9. Actualización del Consenso de la Sociedad Española de Reumatología sobre el uso de antagonistas del TNFα en las espondiloartritis, incluida la artritis psoriásica

Author

Collantes, Eduardo, Fernández Sueiro, José Luis, García-Vicuña, Rosario, Gratacós, Jordi, Mulero, Juan, Muñoz Fernández, Santiago, Sanmartí, Raimon, Zarco, Pedro, Ángel Abad, Miguel, Batlle, Enrique, de Dios Cañete, Juan, González Crespo, María Rosa, González, Carlos, Juanola, Xavier, Sanz, Jesús, and Rivera, Javier

Published
2007
Full Text
View/download PDF

11. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies.

Author

Calvet X, Carpio D, Rodríguez-Lago I, García-Vicuña R, Barreiro-de-Acosta M, Juanola X, Aguas M, Castillo C, and Gratacós J

Subjects
Arthritis, Rheumatoid immunology, COVID-19 etiology, Hepatitis A prevention & control, Hepatitis B prevention & control, Herpes Zoster prevention & control, Humans, Inflammatory Bowel Diseases immunology, Influenza, Human prevention & control, Pneumococcal Infections prevention & control, Risk Factors, Tuberculosis, Pulmonary prevention & control, Vaccination Coverage, Vaccines, Inactivated administration & dosage, Arthritis, Rheumatoid therapy, Bacterial Infections prevention & control, Biological Therapy adverse effects, Immunosuppressive Agents adverse effects, Inflammatory Bowel Diseases therapy, Janus Kinase Inhibitors adverse effects, Virus Diseases prevention & control
Abstract

Patients with certain immune-mediated inflammatory diseases, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD), have an increased risk of severe infectious diseases than the general population, which are mainly associated with the immunosuppressive treatments that they receive. These treatments act on the immune system through different mechanisms, causing different degrees of immunosuppression and a variable risk depending on whether the pathogen is a virus, bacteria or fungus. This article reviews the most relevant literature on the subject, which was selected and discussed by a panel of experts. The aim of this article is to review the risk of infections in patients with IBD and RA, and the potential preventive measures., (Copyright © 2021 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results